MYC and cancer: Nonetheless, the data obtained here are encouraging and show similarities to those retrieved in human cancer research, where PLK1 inhibitory molecules found an application in the treatment of several neoplasia58, 59, 60 promoting clinical trials with drugs indirectly targeting c‐Myc.44